Immune dysfunction, minimal residual disease and patient outcome in non-metastatic cancer; could modulation of immune function improve outcome

dc.contributor.authorMurray, Nigel P
dc.date.accessioned2021-12-17T12:01:15Z
dc.date.available2021-12-17T12:01:15Z
dc.date.issued2021-02
dc.description.abstractImmune modulation by the primary tumour, by surgical resection and adjuvant treatment combined with the biological characteristics of the tumour cell subpopulations will determine patient outcome. In patients with mRD, combined low dose metronomic chemotherapy may improve immune function and the effect of combination therapy to eliminate MRD or may be sufficient to maintain disseminated tumour cells in a dormant state prolonging disease free survival with minimal side effects. the ability to measure and phenotype subtypes of MRD provides an early detection of disease response or progression and determining the most adequate therapy. In asymptomatic patients lower toxicity compared with conventional chemotherapy is importantes
dc.identifier.citationFuture Oncol 2021; 17: 1571-1575 http://doi.org:10.2217/fon-2020-1259es
dc.identifier.issn1479-6694
dc.identifier.orcid0000-0001-8154-8550es
dc.identifier.orcid10.2217/fon-2020-1259
dc.identifier.urihttp://hdl.handle.net/20.500.12254/2139
dc.language.isoenes
dc.publisherFuture Science Groupes
dc.relation.ispartofseriesFuture Oncology;
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/cl/
dc.rights.uri
dc.subject.otherCirculating tumour cellses
dc.subject.otherImmune dysfunctiones
dc.subject.otherMicrometastasises
dc.subject.otherMinimal residual diseasees
dc.subject.otherNon metastatic canceres
dc.subject.otherPrognosises
dc.titleImmune dysfunction, minimal residual disease and patient outcome in non-metastatic cancer; could modulation of immune function improve outcomees
dc.typeArtículoes
dcterms.accessRightsEl artículo completo no puede ser publicado en el Repositorio Institucional debido a los permisos de copyright definidos por la editorial publicadora
Archivos
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
638 B
Formato:
Item-specific license agreed upon to submission
Descripción: